Glenmark Pharma rises nearly 3% on ANDA nod for Rosuvastatin Tablets

Glenmark Pharma rises nearly 3% on ANDA nod for Rosuvastatin Tablets

20/07/2016 12:02

Shares of Glenmark Pharmaceuticals soared nearly 3 per cent on the Bombay Stock Exchange after the drug maker announced that it has received ANDA approval for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base).

Cheering the news, shares of company gained as much as 2.79 per cent in intra-day to trade at Rs 856.50 apiece, against previous closing price of Rs 833.20, on Bombay Stock Exchange.

In a similar fashion, stocks of the company climbed 2.12 per cent to Rs 849.70 apiece on National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 27,895.92, up 108.3 points, or 0.39 per cent, at 12:05 hours.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s